1186231-83-3

Usage

Uses

Used in Oncology:
TAK-441 is used as an antineoplastic agent for its potential to inhibit cancer cell growth. It targets the Par-1 receptor, which is often overexpressed in various cancers, and its suppression can help in managing the disease.
Used in Cancer Treatment Research:
TAK-441 is used as a subject of investigation in the treatment of different types of cancer, including pancreatic cancer. Its role as a Par-1 antagonist makes it a promising candidate for cancer therapy, although there is currently no definitive clinical data confirming its efficacy as a cancer treatment.

Upstream product

• 1186188-72-6 ethyl 6-ethyl-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxylate 
• 1186188-53-3 ethyl 6-ethyl-3-hydroxy-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-4,5-dihydro-1H-pyrrolo-[3,2-c]pyridine-2-carboxylate 
• 1186188-52-2 ethyl 4-chloro-6-ethyl-2-oxo-1-(2-oxo-2-phenylethyl)-1,2-dihydropyridine-3-carboxylate 
• 1186188-51-1 ethyl 4-chloro-6-ethyl-2-oxo-1,2-dihydropyridine-3-carboxylate 
• 125604-20-8 ethyl 6-ethyl-4-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxylate 
• 1186188-73-7 6-ethyl-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxylic acid 
• 883528-73-2 3-amino-4-methyl crotonic acid methylester 
• 30414-53-0 methyl propanoyl acetate 

Downstream Products

• 1268476-89-6 6-ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-5-(2-hydroxy-2-phenylethyl)-1-methyl-4-oxo-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide 

Relevant academic research and scientific papers

FUSED HETEROCYCLIC RING DERIVATIVE AND USE THEREOF

The present invention provides a fused heterocycle derivative having a strong Smo inhibitory activity, and use thereof. Specially, the present invention relates to a compound represented by the formula wherein each symbol is as defined in the specificatio

Discovery of the investigational drug TAK-441, a pyrrolo[3,2-c]pyridine derivative, as a highly potent and orally active hedgehog signaling inhibitor: Modification of the core skeleton for improved solubility

We recently reported the discovery of the novel pyrrolo[3,2-c]quinoline-4- one derivative 1 as a potent inhibitor of Hedgehog (Hh) pathway signaling. However, the PK evaluation of 1 at high dosage (100 mg/kg) revealed the C max value 3.63 μg/mL